Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsored by: |
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) |
---|---|
Information provided by: | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) |
ClinicalTrials.gov Identifier: | NCT00237055 |
Six sites of the Pediatric Inflammatory Bowel Disease Consortium (plus 2 additional sites) will participate in this study. The participating sites will be that of the Principal Investigator (PI), Emory University School of Medicine, Atlanta, GA (Benjamin D. Gold, MD); Texas Children's Hospital / Baylor College of Medicine (George Ferry, MD and Tony Olive, MD); Children's Hospital of Philadelphia, Philadelphia, PA (Bob Baldassano, MD); University of Chicago Children's Hospital, Chicago, IL (Barbara Kirschner, MD); University of California, San Francisco (Mel Heyman, MD); Mass General Hospital / Harvard University (Harland Winter, MD); V.A. Stanford University School of Medicine, Stanford, CA (David Relman, MD); Children's Center For Digestive Healthcare, Atlanta, GA (Stanley Cohen, MD); and Centers for Disease Control and Prevention, Atlanta, GA (Drs. Jeannette Guarner, Siobhan O'Connor and Thomas Shinnick)
The duration of study is 2 yrs.
Objectives:
The study design involves children ages 6 months through 17 11/12 years of age who are undergoing a clinically-indicated colonoscopy. Subjects will be grouped into cases and controls.
Condition |
---|
Crohn's Disease Inflammatory Bowel Disease |
Study Type: | Observational |
Study Design: | Prospective |
Official Title: | Infectious Agents in Pediatric Crohn's Disease |
Estimated Enrollment: | 500 |
Study Start Date: | August 2004 |
Estimated Study Completion Date: | September 2006 |
Ages Eligible for Study: | 6 Months to 18 Years |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Each subject must satisfy all of the following inclusion criteria to be considered eligible for entry into this study:
Exclusion Criteria:
Patients with any of the following characteristics will NOT be eligible for entry into the study:
United States, Georgia | |
Emory University School of Medicine; Emory Children's Center | |
Atlanta, Georgia, United States, 30322 |
Principal Investigator: | Benjamin D. Gold, M.D. | Emory University |
Study ID Numbers: | DK64544, NIDDK R03 DK64544 |
Study First Received: | October 11, 2005 |
Last Updated: | March 24, 2008 |
ClinicalTrials.gov Identifier: | NCT00237055 |
Health Authority: | United States: Federal Government |
Children Crohn's disease Inflammatory bowel disease Infectious agents Colonoscopy |
Digestive System Diseases Crohn’s disease, pediatric Gastrointestinal Diseases Crohn Disease |
Inflammatory Bowel Diseases Gastroenteritis Intestinal Diseases |